Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Vaccine - Page 45

Vaccine

Moderna announced primary efficacy analysis in phase 3 COVE study for COVID-19 vaccine candidate
Biotechnology | Diagnostics | FDA | Infectious Disease | Vaccine

Moderna announced primary efficacy analysis in phase 3 COVE study for COVID-19 vaccine candidate

On Nov. 30, 2020, Moderna announced that the primary efficacy analysis of the Phase 3 study of mRNA-1273…

Read More Moderna announced primary efficacy analysis in phase 3 COVE study for COVID-19 vaccine candidateContinue

Novavax announced COVID-19 vaccine clinical development progress
Biotechnology | Infectious Disease | Vaccine

Novavax announced COVID-19 vaccine clinical development progress

On Nov. 30, 2020, Novavax announced that two of the three planned late-stage efficacy trials for NVX-CoV2373 sponsored…

Read More Novavax announced COVID-19 vaccine clinical development progressContinue

Moderna amended supply agreement with UK Government for 2 million doses of mRNA COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna amended supply agreement with UK Government for 2 million doses of mRNA COVID-19 vaccine

On Nov. 29, 2020, Moderna announced a supply agreement with the United Kingdom (UK) government for an additional…

Read More Moderna amended supply agreement with UK Government for 2 million doses of mRNA COVID-19 vaccineContinue

Moderna announced EC approval of purchase agreement for 80 million doses of mRNA COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced EC approval of purchase agreement for 80 million doses of mRNA COVID-19 vaccine

On Nov. 25, 2020, Moderna announced that the European Commission (EC) has approved an agreement to secure 80…

Read More Moderna announced EC approval of purchase agreement for 80 million doses of mRNA COVID-19 vaccineContinue

BioNTech and Fosun Pharma announced start of phase 2 clinical trial of mRNA COVID-19 vaccine in China
COVID-19 | Life Science History | Vaccine

BioNTech and Fosun Pharma announced start of phase 2 clinical trial of mRNA COVID-19 vaccine in China

On Nov. 25, 2020, BioNTech and Shanghai Fosun Pharmaceutica jointly announced that their lead mRNA COVID-19 vaccine candidate…

Read More BioNTech and Fosun Pharma announced start of phase 2 clinical trial of mRNA COVID-19 vaccine in ChinaContinue

Roche announced FDA approval of Xofluza for prevention of influenza following contact with infected person
Biotechnology | Infectious Disease | Influenza | Vaccine

Roche announced FDA approval of Xofluza for prevention of influenza following contact with infected person

On Nov. 24, 2020, Roche announced that the U.S. Food and Drug Administration (FDA) had approved a supplemental…

Read More Roche announced FDA approval of Xofluza for prevention of influenza following contact with infected personContinue

NeuroRx and Relief announced successful results from expanded use of RLF-100 in patients with COVID-19
Biotechnology | COVID-19 | Disease | Therapeutics | Vaccine

NeuroRx and Relief announced successful results from expanded use of RLF-100 in patients with COVID-19

On Nov. 24, 2020, RELIEF THERAPEUTICS announced that more than 175 patients with Critical COVID-19 and Respiratory Failure…

Read More NeuroRx and Relief announced successful results from expanded use of RLF-100 in patients with COVID-19Continue

MediciNova announced initiation of master virus seed stock production for intranasal COVID-19 vaccine
COVID-19 | Life Science History | Vaccine

MediciNova announced initiation of master virus seed stock production for intranasal COVID-19 vaccine

On Nov. 24, 2020, MediciNova announced development progress on its intranasal SARS-CoV-2 vaccine for COVID-19 utilizing BC-PIV, a…

Read More MediciNova announced initiation of master virus seed stock production for intranasal COVID-19 vaccineContinue

Oxford University reported breakthrough on global COVID-19 vaccine
COVID-19 | Life Science History | Vaccine

Oxford University reported breakthrough on global COVID-19 vaccine

On Nov. 23, 2020, the University of Oxford, in collaboration with AstraZeneca, announced interim trial data from its…

Read More Oxford University reported breakthrough on global COVID-19 vaccineContinue

AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
COVID-19 | Life Science History | Vaccine

AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19

On Nov. 23, 2020, AstraZeneca announced positive high-level results from an interim analysis of clinical trials of AZD1222…

Read More AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19Continue

Avian influenza virus spread rapidly in Europe
Biotechnology | Diagnostics | Infectious Disease | Influenza | Vaccine

Avian influenza virus spread rapidly in Europe

On Nov. 20, 2020, the ‘European Food Safety Authority reported that within the past month more than 300…

Read More Avian influenza virus spread rapidly in EuropeContinue

Oxford Coronavirus vaccine produced strong immune response in older adults
COVID-19 | Life Science History | Vaccine

Oxford Coronavirus vaccine produced strong immune response in older adults

On Nov. 19, 2020, the University of Oxford announced that the ChAdOx1 nCov-2019 coronavirus vaccine had been shown…

Read More Oxford Coronavirus vaccine produced strong immune response in older adultsContinue

Medigen Vaccines announced publication of positive results from preclinical studies of COVID-19 vaccine candidate
Biotechnology | COVID-19 | Therapeutics | Vaccine

Medigen Vaccines announced publication of positive results from preclinical studies of COVID-19 vaccine candidate

On Nov. 19, 2020, Medigen Vaccine Biologics announced that preclinical results of their COVID-19 vaccine candidate had been…

Read More Medigen Vaccines announced publication of positive results from preclinical studies of COVID-19 vaccine candidateContinue

ApiJect approved for $590 million loan from US International DFC to build drug manufacturing facility in North Carolina
COVID-19 | Life Science History | Vaccine

ApiJect approved for $590 million loan from US International DFC to build drug manufacturing facility in North Carolina

On Nov. 19, 2020, ApiJect Systems, a public benefit corporatio, announced that it had been approved by the…

Read More ApiJect approved for $590 million loan from US International DFC to build drug manufacturing facility in North CarolinaContinue

Pfizer and BioNTech announced phase 3 study of COVID-19 vaccine candidate met all efficacy endpoints
COVID-19 | Life Science History | Vaccine

Pfizer and BioNTech announced phase 3 study of COVID-19 vaccine candidate met all efficacy endpoints

On Nov. 18, 2020, Pfizer and BioNTech announced that, after conducting the final efficacy analysis in their ongoing…

Read More Pfizer and BioNTech announced phase 3 study of COVID-19 vaccine candidate met all efficacy endpointsContinue

CureVac established European-based network for manufacturing of COVID-19 vaccine candidate, CVnCoV
COVID-19 | Life Science History | Vaccine

CureVac established European-based network for manufacturing of COVID-19 vaccine candidate, CVnCoV

On Nov. 17, 2020, CureVac announced that it had accelerated the expansion of its manufacturing network to deliver…

Read More CureVac established European-based network for manufacturing of COVID-19 vaccine candidate, CVnCoVContinue

Moderna announced supply agreement with UK Government to supply mRNA vaccine against COVID-19
COVID-19 | Infectious Disease | Vaccine

Moderna announced supply agreement with UK Government to supply mRNA vaccine against COVID-19

On Nov. 17, 2020, Moderna announced a supply agreement with the government of the United Kingdom (UK) to…

Read More Moderna announced supply agreement with UK Government to supply mRNA vaccine against COVID-19Continue

Celdara Medical secured SBIR funding to develop an adjuvanted universal flu vaccine
Biotechnology | Infectious Disease | Influenza | NIH | Vaccine

Celdara Medical secured SBIR funding to develop an adjuvanted universal flu vaccine

On Nov. 17, 2020, Celdara Medical announced that the National Institute of Allergy and Infectious Disease (NIAID) of…

Read More Celdara Medical secured SBIR funding to develop an adjuvanted universal flu vaccineContinue

Wellcome Sanger Institute and COG-UK received £122M UK investment for COVID-19 genomic surveillance
Biotechnology | COVID-19 | Diagnostics | Genomics | Infectious Disease | Therapeutics | Vaccine

Wellcome Sanger Institute and COG-UK received £122M UK investment for COVID-19 genomic surveillance

On Nov. 16, 2020, the UK Department for Health and Social Care Testing Innovation Fund announced £12.2M funding…

Read More Wellcome Sanger Institute and COG-UK received £122M UK investment for COVID-19 genomic surveillanceContinue

Biological E Limited started phase I/II clinical trial of its COVID-19 vaccine candidate
COVID-19 | Life Science History | Vaccine

Biological E Limited started phase I/II clinical trial of its COVID-19 vaccine candidate

On Nov. 16, 2020, Biological E. Limited (BE), a Hyderabad-based vaccines and pharmaceutical company, Dynavax Technologies, and Baylor…

Read More Biological E Limited started phase I/II clinical trial of its COVID-19 vaccine candidateContinue

Moderna announced longer shelf life for its COVID-19 vaccine candidate at refrigerated temperatures
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced longer shelf life for its COVID-19 vaccine candidate at refrigerated temperatures

On Nov. 16, 2020, Moderna announced new data showing that mRNA-1273, its COVID-19 vaccine candidate, remained stable at…

Read More Moderna announced longer shelf life for its COVID-19 vaccine candidate at refrigerated temperaturesContinue

Tonix Pharmaceuticals reported positive immune response results from COVID-19 Vaccine candidate
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Vaccine

Tonix Pharmaceuticals reported positive immune response results from COVID-19 Vaccine candidate

On Nov. 16, 2020, Tonix Pharmaceuticals announced preliminary results following vaccination of non-human primates with TNX-1800 (modified horsepox…

Read More Tonix Pharmaceuticals reported positive immune response results from COVID-19 Vaccine candidateContinue

BioNTech and Fosun Pharma approved to commence COVID-19 vaccine candidate BNT162b2 trial in China
Life Science History | Vaccine

BioNTech and Fosun Pharma approved to commence COVID-19 vaccine candidate BNT162b2 trial in China

On Nov. 16, 2020, BioNTech and Shanghai Fosun Pharmaceutica announced that the China National Medical Products Administration had…

Read More BioNTech and Fosun Pharma approved to commence COVID-19 vaccine candidate BNT162b2 trial in ChinaContinue

INOVIO announced initiation of phase 2/3 clinical trial for COVID-19 DNA vaccine candidate, INO-4800
Biotechnology | COVID-19 | FDA | Infectious Disease | Vaccine

INOVIO announced initiation of phase 2/3 clinical trial for COVID-19 DNA vaccine candidate, INO-4800

On Nov. 16, 2020, INOVIO announced that it had received clearance from the the U.S. Food & Drug…

Read More INOVIO announced initiation of phase 2/3 clinical trial for COVID-19 DNA vaccine candidate, INO-4800Continue

European Medicines Agency began rolling review of Moderna’s mRNA vaccine candidate against COVID-19
Biotechnology | COVID-19 | Infectious Disease | Life Science History | Vaccine

European Medicines Agency began rolling review of Moderna’s mRNA vaccine candidate against COVID-19

On Nov. 16, 2020, Moderna announced that the European Medicines Agency (EMA) human medicines committee (CHMP) had started…

Read More European Medicines Agency began rolling review of Moderna’s mRNA vaccine candidate against COVID-19Continue

Johnson & Johnson Initiated second global phase 3 clinical trial of Janssen COVID-19 vaccine candidate
COVID-19 | Life Science History | Vaccine

Johnson & Johnson Initiated second global phase 3 clinical trial of Janssen COVID-19 vaccine candidate

On Nov. 15, 2020, Johnson & Johnson announced that it continued to enroll and vaccinate study participants for…

Read More Johnson & Johnson Initiated second global phase 3 clinical trial of Janssen COVID-19 vaccine candidateContinue

Moderna’s COVID-19 vaccine candidate met primary endpoint in first interim analysis of phase 3 COVE study
Biotechnology | COVID-19 | Infectious Disease | Life Science History | NIH | Vaccine

Moderna’s COVID-19 vaccine candidate met primary endpoint in first interim analysis of phase 3 COVE study

On Nov. 15, 2020, an independent data and safety monitoring board (DSMB) overseeing the Phase 3 trial of…

Read More Moderna’s COVID-19 vaccine candidate met primary endpoint in first interim analysis of phase 3 COVE studyContinue

Swissmedic began rolling review of Moderna’s mRNA vaccine against COVID-19
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Vaccine

Swissmedic began rolling review of Moderna’s mRNA vaccine against COVID-19

On Nov. 13, 2020, Moderna announced that Swissmedic had started a rolling review of mRNA-1273, the Company’s vaccine…

Read More Swissmedic began rolling review of Moderna’s mRNA vaccine against COVID-19Continue

Gates Foundation announced funds to develop COVID-19 vaccines and increase access in low-income countries
COVID-19 | Non-Profit Research | Vaccine

Gates Foundation announced funds to develop COVID-19 vaccines and increase access in low-income countries

On Nov. 12, 2020, the Bill & Melinda Gates Foundation announced new commitments totaling $70 million to global…

Read More Gates Foundation announced funds to develop COVID-19 vaccines and increase access in low-income countriesContinue

Vaxart announced additional data from Hamster Challenge Study of its oral COVID-19 vaccine
Life Science History | Vaccine

Vaxart announced additional data from Hamster Challenge Study of its oral COVID-19 vaccine

On Nov. 12, 2020 Vaxart announced additional results from its Hamster Challenge Study. The study evaluated Vaxartメs recombinant…

Read More Vaxart announced additional data from Hamster Challenge Study of its oral COVID-19 vaccineContinue

Page navigation

Previous PagePrevious 1 … 43 44 45 46 47 … 78 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiovascular
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search